Efficacy and safety of ceritinib in ALK-positive non-small cell lung cancer (NSCLC) patients with leptomeningeal metastases (LM): Results from the phase II, ASCEND-7 study
暂无分享,去创建一个
P. Wen | H. Wakelee | L. Chow | M. Shi | F. Barlesi | Chong-Jen Yu | F. K. Hurtado | E. Bertino | M. McKeage | M. Bent | Yuanbo Song | M. Majem | P. López | S. Orlov | D. Kim | P. C. Arratia | Fabrice Branle